These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Wollenberg A, Reitamo S, Atzori F, Lahfa M, Ruzicka T, Healy E, Giannetti A, Bieber T, Vyas J, Deleuran M, European Tacrolimus Ointment Study Group. Allergy; 2008 Jun; 63(6):742-50. PubMed ID: 18445188 [Abstract] [Full Text] [Related]
45. Long-term treatment with 0.1% tacrolimus ointment in adults with atopic dermatitis: results of a two-year, multicentre, non-comparative study. Reitamo S, Ortonne JP, Sand C, Bos J, Cambazard F, Bieber T, Grønhøj-Larsen C, Rustin M, Fölster-Holst R, Schuttelaar M, European Tacrolimus Ointment Study Group. Acta Derm Venereol; 2007 Jun; 87(5):406-12. PubMed ID: 17721647 [Abstract] [Full Text] [Related]
46. Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle. Breneman D, Fleischer AB, Abramovits W, Zeichner J, Gold MH, Kirsner RS, Shull TF, Crowe AW, Jaracz E, Hanifin JM, Tacrolimus Ointment Study Group. J Am Acad Dermatol; 2008 Jun; 58(6):990-9. PubMed ID: 18359127 [Abstract] [Full Text] [Related]
57. Quality of life in patients with atopic dermatitis: impact of tacrolimus ointment. Kawashima M, QOL Research Forum for Patients with Atopic Dermatitis. Int J Dermatol; 2006 Jun; 45(6):731-6. PubMed ID: 16796638 [Abstract] [Full Text] [Related]